ArticleClinical diabetes : a publication of the American Diabetes Association2023

Tirzepatide: A Novel Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide 1 Receptor Agonist for the Treatment of Type 2 Diabetes: The First Twincretin.

Alexis V Fanshier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.